WatchFrog Overview

  • Founded
  • 2005
  • Status
  • Private
  • Employees
  • 13
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $1.7M
Latest Deal Amount
  • Investors
  • 3

WatchFrog General Information


Developer of biotechnological tools designed to measure the effects of endocrine disruptors on the living. The company's tools detect pollutants and contaminants in drinking water by using amphibian and fish larvae which become fluorescent in the presence of endocrine disruptors, heavy metals, or other pollutants in the water, enabling industrial clients and local communities to monitor the presence and level of pollutants in their products or in plant discharges.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Environmental Services (B2B)
Laboratory Services (Healthcare)
Primary Office
  • 4 rue Pierre Fontaine
  • 91000 Paris
  • France
+33 01 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

WatchFrog Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 04-Mar-2015 $1.7M 00.000 Completed Generating Revenue
2. Early Stage VC (Series A) 26-May-2008 00000 00000 00.000 Completed Startup
1. Accelerator/Incubator Completed Startup
To view WatchFrog’s complete valuation and funding history, request access »

WatchFrog Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
P Shares 00,000 00.000000 000.0 000.0 00 000.0 00.000
P Shares 0,000 00.000000 000.00 000.00 00 000.00 00
P Shares 0,000 00.000000 000.00 000.00 00 000.00 0.00
P Shares 10,520 $1.131752 $37.65 $37.65 1x $37.65 15.17%
O Shares 40,572 $1.131752
To view WatchFrog’s complete cap table history, request access »

WatchFrog Executive Team (4)

Name Title Board Seat Contact Info
Barbara Demeneix Ph.D Co-Founder, Deputy Scientific Director & Chairman of the Scientific Council
Gregory Lemkine Ph.D Co-Founder, Chief Executive Officer & Partner
Corinne Pericard Finance & Administration Manager
David Du Pasquier Chercheur, Responsable de l'équipe R&D
To view WatchFrog’s complete executive team members history, request access »

WatchFrog Board Members (2)

Name Representing Role Since
Barbara Demeneix Ph.D WatchFrog Co-Founder, Deputy Scientific Director & Chairman of the Scientific Council 000 0000
Catherine Boule Karista (France) Board Member 000 0000
To view WatchFrog’s complete board members history, request access »

WatchFrog Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

WatchFrog Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Chevrillon & Associés Family Office Minority 000 0000 000000 0
Karista (France) Venture Capital Minority 000 0000 000000 0
IncubAlliance Accelerator/Incubator Minority 000 0000 000000 0
To view WatchFrog’s complete investors history, request access »